Lucid Diagnostics Inc. – NASDAQ:LUCD
Lucid Diagnostics stock price today
$1.01
+0.22
+28.17%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 3 days
Lucid Diagnostics stock price monthly change
-8.91%
month
Lucid Diagnostics stock price quarterly change
-8.91%
quarter
Lucid Diagnostics stock price yearly change
-45.28%
year
Lucid Diagnostics key metrics
Market Cap | 46.19M |
Enterprise value | 31.97M |
P/E | -0.97 |
EV/Sales | 84.81 |
EV/EBITDA | -0.58 |
Price/Sales | 139.12 |
Price/Book | 2.27 |
PEG ratio | 0.36 |
EPS | -1.11 |
Revenue | 2.98M |
EBITDA | -45.33M |
Income | -47.03M |
Revenue Q/Q | 124.43% |
Revenue Y/Y | 370.50% |
Profit margin | -14899.47% |
Oper. margin | -14853.58% |
Gross margin | -858.36% |
EBIT margin | -14853.58% |
EBITDA margin | -1519.88% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeLucid Diagnostics stock price history
Lucid Diagnostics stock forecast
Lucid Diagnostics financial statements
Average Price Target
$2.5
Potential upside: 147.52%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 159K | -11.38M | -7157.86% |
|---|---|---|---|
| Sep 2023 | 783K | -14.20M | -1814.56% |
| Dec 2023 | 1.04M | -10.83M | -1041.35% |
| Mar 2024 | 1.00M | -10.61M | -1060.14% |
| 2024-03-25 | -0.26 | -0.23 |
|---|---|---|
| 2024-05-13 | -0.27 | -0.21 |
| Jun 2023 | 42486000 | 27.41M | 64.53% |
|---|---|---|---|
| Sep 2023 | 33244000 | 30.68M | 92.31% |
| Dec 2023 | 27270000 | 29.58M | 108.47% |
| Mar 2024 | 32048000 | 20.15M | 62.89% |
| Jun 2023 | -7.01M | -15K | 75K |
|---|---|---|---|
| Sep 2023 | -8.78M | -14K | 275K |
| Dec 2023 | -9.97M | -175K | 5M |
| Mar 2024 | -12.61M | -37K | 18.52M |
Lucid Diagnostics alternative data
| Mar 2024 | 70 |
|---|---|
| Apr 2024 | 70 |
| May 2024 | 70 |
| Jun 2024 | 70 |
| Jul 2024 | 70 |
Lucid Diagnostics other data
0.50%
-9.80%
of LUCD is owned by hedge funds
92.28K
-1.82M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Sep 2023 | 0 | 33964 |
| Quarter | Transcript |
|---|---|
| Q3 2024 13 May 2024 | Q3 2024 Earnings Call Transcript |
| Q1 2024 13 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 26 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 14 Nov 2023 | Q3 2023 Earnings Call Transcript |
-
What's the price of Lucid Diagnostics stock today?
One share of Lucid Diagnostics stock can currently be purchased for approximately $1.01.
-
When is Lucid Diagnostics's next earnings date?
Unfortunately, Lucid Diagnostics's (LUCD) next earnings date is currently unknown.
-
Does Lucid Diagnostics pay dividends?
No, Lucid Diagnostics does not pay dividends.
-
How much money does Lucid Diagnostics make?
Lucid Diagnostics has a market capitalization of 46.19M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 544.03% to 2.43M US dollars. Lucid Diagnostics made a loss 52.67M US dollars in net income (profit) last year or -$0.21 on an earnings per share basis.
-
What is Lucid Diagnostics's stock symbol?
Lucid Diagnostics Inc. is traded on the NASDAQ under the ticker symbol "LUCD".
-
What is Lucid Diagnostics's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Lucid Diagnostics?
Shares of Lucid Diagnostics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Lucid Diagnostics have?
As Jul 2024, Lucid Diagnostics employs 70 workers.
-
When Lucid Diagnostics went public?
Lucid Diagnostics Inc. is publicly traded company for more then 3 years since IPO on 14 Oct 2021.
-
What is Lucid Diagnostics's official website?
The official website for Lucid Diagnostics is luciddx.com.
-
Where are Lucid Diagnostics's headquarters?
Lucid Diagnostics is headquartered at One Grand Central Place, New York, NY.
-
How can i contact Lucid Diagnostics?
Lucid Diagnostics's mailing address is One Grand Central Place, New York, NY and company can be reached via phone at +212 9494319.
-
What is Lucid Diagnostics stock forecast & price target?
Based on 1 Wall Street analysts` predicted price targets for Lucid Diagnostics in the last 12 months, the avarage price target is $2.5. The average price target represents a 147.52% change from the last price of $1.01.
Lucid Diagnostics company profile:
Lucid Diagnostics Inc.
luciddx.comExchange:
NASDAQ
Full time employees:
70
Industry:
Medical - Devices
Sector:
Healthcare
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its lead products include EsoGuard, a laboratory developed esophageal DNA test; and EsoCheck, an esophageal cell collection device. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.
One Grand Central Place
New York, NY 10165
New York, NY 10165
CIK: 0001799011
ISIN: US54948X1090
CUSIP: 54948X109
